Contrast-induced nephropathy: The wheel has turned 360 degrees
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Contrast-induced nephropathy: The wheel has turned 360 degrees. / Thomsen, H.S.; Morcos, S.K.; Barrett, B.J.; Thomsen, Henrik S.
In: Acta Radiologica, Vol. 49, No. 6, 2008, p. 646-657.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Contrast-induced nephropathy: The wheel has turned 360 degrees
AU - Thomsen, H.S.
AU - Morcos, S.K.
AU - Barrett, B.J.
AU - Thomsen, Henrik S.
N1 - Times Cited: 0ReviewEnglishThomsen, H. SUniv Copenhagen, Herlev Hosp, Dept Diagnost Radiol 54E2, Herlev Ringvej 75, DK-2730 Herlev, DenmarkCited References Count: 106316VRTAYLOR & FRANCIS LTD4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLANDABINGDON
PY - 2008
Y1 - 2008
N2 - Contrast-induced nephropathy (CIN) has been a hot topic during the last 5 years due its association with increased morbidity and mortality. CIN is an important complication, particularly in patients with advanced chronic kidney disease (CKD) associated with diabetes mellitus. Methods to diminish the incidence of CIN have been highly contentious. They include choice of contrast, pharmacologic manipulation, and volume expansion. The pathophysiology of this complication remains uncertain, but reduction in renal blood flow and direct toxicity of tubular cells has been implicated. More than 900 publications under the heading CIN have been published during the last 5 years. Fewer than 5% of these publications are randomized prospective controlled studies. In spite of the large number of reports on CIN, very little has been changed. The use of the smallest possible dose of low- or iso-osmolar contrast media, volume expansion, stopping nephrotoxic drugs, and avoiding repeat contrast injections within 48 hours remain the most effective approach to reduce the risk of CIN Udgivelsesdato: 2008
AB - Contrast-induced nephropathy (CIN) has been a hot topic during the last 5 years due its association with increased morbidity and mortality. CIN is an important complication, particularly in patients with advanced chronic kidney disease (CKD) associated with diabetes mellitus. Methods to diminish the incidence of CIN have been highly contentious. They include choice of contrast, pharmacologic manipulation, and volume expansion. The pathophysiology of this complication remains uncertain, but reduction in renal blood flow and direct toxicity of tubular cells has been implicated. More than 900 publications under the heading CIN have been published during the last 5 years. Fewer than 5% of these publications are randomized prospective controlled studies. In spite of the large number of reports on CIN, very little has been changed. The use of the smallest possible dose of low- or iso-osmolar contrast media, volume expansion, stopping nephrotoxic drugs, and avoiding repeat contrast injections within 48 hours remain the most effective approach to reduce the risk of CIN Udgivelsesdato: 2008
M3 - Journal article
VL - 49
SP - 646
EP - 657
JO - Acta Radiologica - Series Diagnosis
JF - Acta Radiologica - Series Diagnosis
SN - 0365-5954
IS - 6
ER -
ID: 13911373